Findings showed the study did not meet its primary endpoint of preventing CMV infection in seronegative participants. Topline results were announced from a phase 3 study evaluating Moderna’s ...
Researchers at the University of California San Diego have discovered a promising new treatment approach for pancreatic cancer, one of the deadliest and most treatment-resistant forms of cancer. The ...
COPENHAGEN, Denmark, November 12, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, announces new ...
Cytomegalovirus, or CMV, is a common infection in both adults and children. Clinical trials for several vaccines are currently underway to help prevent people from developing CMV. The Centers for ...
Moderna’s CMV Vaccine Extension Study Reaches Completion, Setting the Stage for Next Growth Catalyst
Moderna’s latest clinical update centers on a long‑term extension of its cytomegalovirus (CMV) vaccine program, officially titled “A Phase 2, Non-Randomized, Long-Term Extension Study to Evaluate the ...
New York is now screening all newborns for congenital Cytomegalovirus to improve access to early treatments for the viral infection that can cause hearing and vision loss, seizures and intellectual ...
* VBI Vaccines Inc - no safety signals have been detected, suggesting vbi's cmv vaccine candidate is safe and well-tolerated * VBI Vaccines Inc - an interim safety and immunogenicity report, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results